These proprietary complexes combine GHK-Cu with additional copper-binding peptides designed to work synergistically
How This Works Tirzepatide is a novel dual agonist that simultaneously activates GLP1 (glucagonlike peptide1) and GIP (glucosedependent insulinotropic polypeptide) receptors [1] [2]
Receptor binding kinetics matter
Ren X, Zou L, Zhang X, Branco V, Wang J, Carvalho C, et al
This makes it a useful tool for researchers studying: Regulation of adipose tissue metabolism Energy balance and obesity-related pathways Joint and cartilage biology in osteoarthritis models Metabolic factors associated with cardiovascular and systemic syndromes In animal studies, AOD9604 has been reported to stimulate lipolysis and inhibit lipogenesis under specific experimental conditions, providing a platform to dissect signaling mechanisms involved in fat turnover and metabolic control
Athletic Recovery: Support muscle recovery, hydration, and performance with recovery-focused IV treatments
